Stock Analysis on Net

Cigna Group (NYSE:CI)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 27, 2025.

Common-Size Balance Sheet: Assets

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Cigna Group, common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Cash and cash equivalents
Investments
Noninsurance customer receivables
Pharmaceutical manufacturers receivable
Insurance customer receivables
Other receivables
Less: Accounts receivable, net classified as Assets of businesses held for sale
Accounts receivable, net
Inventories
Other current assets
Assets of businesses held for sale
Current assets
Long-term investments
Reinsurance recoverables
Property and equipment
Goodwill
Other intangible assets
Other assets
Separate account assets
Assets of businesses held for sale, non-current
Non-current assets
Total assets

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


Cash and Cash Equivalents
The proportion of cash and cash equivalents relative to total assets declined significantly from 6.55% in 2020 to 3.28% in 2021. It then recovered in the following years, reaching 5.12% in 2023 before slightly decreasing to 4.84% in 2024. This indicates a fluctuating liquidity position over the period.
Investments
Investment holdings as a percentage of total assets exhibited a steady decline, starting at 0.86% in 2020 and decreasing to 0.43% by 2024, signifying a reduced emphasis on investments in the asset portfolio.
Accounts Receivable Categories
Noninsurance customer receivables showed a consistent upward trend, increasing from 3.56% to 7.62% over the five-year span, suggesting growth in receivables from noninsurance activities. Pharmaceutical manufacturers receivables also rose markedly from 3.01% to 7.00%, showing an expanding exposure or more sales in this sector. Insurance customer receivables fluctuated, rising from 1.15% in 2020 to a peak of 2.06% in 2022, then dipping to 1.54% before rebounding to 2.05% in 2024. Other receivables maintained low proportions throughout, with minor variation. Notably, accounts receivable, net, increased substantially from 7.84% in 2020 to 15.54% in 2024, supporting the trend of growing receivables overall. Adjustments for receivables classified as assets of businesses held for sale appear as negative values, contributing to variability in net accounts receivable figures.
Inventories and Other Current Assets
Inventories steadily increased from 2.04% to 4.29%, indicating greater stock levels or inventory holdings. Other current assets also grew from 0.60% to 1.75%, which may reflect rising prepaid expenses or other short-term asset components.
Assets of Businesses Held for Sale and Current Assets
Assets of businesses held for sale showed intermittent values, appearing at 6.49% in 2021, decreasing in subsequent years but rising again to 4.49% in 2024, suggesting active restructuring or divestitures. Overall current assets increased significantly from 17.88% in 2020 to 31.35% by 2024, indicating a growing share of short-term assets in the total asset base.
Long-term Investments and Reinsurance Recoverables
Long-term investments diminished consistently from 14.96% to 9.70%, indicating strategic reducing of such investments. Reinsurance recoverables remained relatively stable with a slight decline from 3.35% to 2.81%, showing minor changes in reinsurance asset exposure.
Property, Equipment, and Intangible Assets
Property and equipment assets showed a gradual decline from 2.71% to 2.34%. Goodwill increased slightly from 28.72% to a peak of 31.83% in 2022, before declining to 28.46% in 2024, reflecting some adjustments in acquired intangible assets or impairments. Other intangible assets consistently decreased from 22.63% to 18.87%, indicating amortization or impairment effects.
Other Assets
Other assets decreased from 3.91% in 2020 to 1.79% in 2024, implying reduced holdings in miscellaneous asset categories. Separate account assets also showed a decreasing trend from 5.84% to 4.67%, indicating less investment in accounts segregated for policyholders or beneficiaries.
Non-current Assets and Total Assets
Non-current assets as a portion of total assets declined from 82.12% to 68.65%, contrasting with the increase in current assets over the same period, highlighting a shift toward greater liquidity or short-term asset composition. Total assets always represent 100%, serving as the denominator for all ratios.